Study to Assess Amphotericin B Cystetic for Inhalation (ABCI) Doses in Healthy Volunteers & People with Cystic Fibrosis
Clinical trial NCT05802264 · RECRUITING
Trial details
- NCT number
- NCT05802264
- Sponsor
- Cystetic Medicines, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-21
- Primary completion
- 2025-12-01
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.